Year |
Citation |
Score |
2020 |
Tracy AN, Yadavalli R, Reed KS, Parnaik R, Poulton NJ, Bishop-Bailey D, Fernández Robledo JA. Genome to phenome tools: In vivo and in vitro transfection of Crassostrea virginica hemocytes. Fish & Shellfish Immunology. PMID 32450301 DOI: 10.1016/J.Fsi.2020.05.022 |
0.312 |
|
2020 |
Edin ML, Lih FB, Hammock BD, Thomson S, Zeldin DC, Bishop-Bailey D. Vascular Lipidomic Profiling of Potential Endogenous Fatty Acid PPAR Ligands Reveals the Coronary Artery as Major Producer of CYP450-Derived Epoxy Fatty Acids. Cells. 9. PMID 32365470 DOI: 10.3390/Cells9051096 |
0.355 |
|
2019 |
Cho H, Yadav AK, Do Y, Heo M, Bishop-Bailey D, Lee J, Jang BC. Anti‑survival and pro‑apoptotic effects of meridianin C derivatives on MV4‑11 human acute myeloid leukemia cells. International Journal of Oncology. PMID 31789392 DOI: 10.3892/Ijo.2019.4925 |
0.551 |
|
2018 |
Park NS, Park YK, Ramalingam M, Yadav AK, Cho HR, Hong VS, More KN, Bae JH, Bishop-Bailey D, Kano J, Noguchi M, Jang IS, Lee KB, Lee J, Choi JS, et al. Meridianin C inhibits the growth of YD-10B human tongue cancer cells through macropinocytosis and the down-regulation of Dickkopf-related protein-3. Journal of Cellular and Molecular Medicine. PMID 30246484 DOI: 10.1111/jcmm.13854 |
0.559 |
|
2016 |
Moraes LA, Unsworth AJ, Vaiyapuri S, Ali MS, Sasikumar P, Sage T, Flora GD, Bye AP, Kriek N, Dorchies E, Molendi-Coste O, Dombrowicz D, Staels B, Bishop-Bailey D, Gibbins JM. Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 27758768 DOI: 10.1161/Atvbaha.116.308093 |
0.366 |
|
2016 |
Gilroy DW, Edin ML, De Maeyer RP, Bystrom J, Newson J, Lih FB, Stables M, Zeldin DC, Bishop-Bailey D. CYP450-derived oxylipins mediate inflammatory resolution. Proceedings of the National Academy of Sciences of the United States of America. PMID 27226306 DOI: 10.1073/Pnas.1521453113 |
0.368 |
|
2015 |
Kirkby NS, Reed DM, Edin ML, Rauzi F, Mataragka S, Vojnovic I, Bishop-Bailey D, Milne GL, Longhurst H, Zeldin DC, Mitchell JA, Warner TD. Inherited human group IVA cytosolic phospholipase A2 deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 26183771 DOI: 10.1096/Fj.15-275065 |
0.314 |
|
2015 |
Thomson S, Edin ML, Lih FB, Davies M, Yaqoob MM, Hammock BD, Gilroy D, Zeldin DC, Bishop-Bailey D. Intimal smooth muscle cells are a source but not a sensor of anti-inflammatory CYP450 derived oxylipins. Biochemical and Biophysical Research Communications. PMID 26086108 DOI: 10.1016/J.Bbrc.2015.06.012 |
0.446 |
|
2015 |
Bishop-Bailey D. Nuclear receptors in vascular biology. Current Atherosclerosis Reports. 17: 507. PMID 25772409 DOI: 10.1007/S11883-015-0507-8 |
0.39 |
|
2014 |
Faulkner A, Purcell R, Hibbert A, Latham S, Thomson S, Hall WL, Wheeler-Jones C, Bishop-Bailey D. A thin layer angiogenesis assay: a modified basement matrix assay for assessment of endothelial cell differentiation. Bmc Cell Biology. 15: 41. PMID 25476021 DOI: 10.1186/S12860-014-0041-5 |
0.313 |
|
2014 |
Bishop-Bailey D, Thomson S, Askari A, Faulkner A, Wheeler-Jones C. Lipid-metabolizing CYPs in the regulation and dysregulation of metabolism. Annual Review of Nutrition. 34: 261-79. PMID 24819323 DOI: 10.1146/Annurev-Nutr-071813-105747 |
0.32 |
|
2014 |
Askari AA, Thomson S, Edin ML, Lih FB, Zeldin DC, Bishop-Bailey D. Basal and inducible anti-inflammatory epoxygenase activity in endothelial cells. Biochemical and Biophysical Research Communications. 446: 633-7. PMID 24631907 DOI: 10.1016/J.Bbrc.2014.03.020 |
0.412 |
|
2013 |
Bystrom J, Thomson SJ, Johansson J, Edin ML, Zeldin DC, Gilroy DW, Smith AM, Bishop-Bailey D. Inducible CYP2J2 and its product 11,12-EET promotes bacterial phagocytosis: a role for CYP2J2 deficiency in the pathogenesis of Crohn's disease? Plos One. 8: e75107. PMID 24058654 DOI: 10.1371/Journal.Pone.0075107 |
0.388 |
|
2013 |
Askari A, Thomson SJ, Edin ML, Zeldin DC, Bishop-Bailey D. Roles of the epoxygenase CYP2J2 in the endothelium. Prostaglandins & Other Lipid Mediators. 107: 56-63. PMID 23474289 DOI: 10.1016/J.Prostaglandins.2013.02.003 |
0.372 |
|
2012 |
Aihara K, Mogi M, Shibata R, Bishop-Bailey D, Reilly MP. Inflammation and vascular remodeling. International Journal of Vascular Medicine. 2012: 596796. PMID 23209907 DOI: 10.1155/2012/596796 |
0.356 |
|
2012 |
Thomson SJ, Askari A, Bishop-Bailey D. Anti-inflammatory effects of epoxyeicosatrienoic acids. International Journal of Vascular Medicine. 2012: 605101. PMID 22848834 DOI: 10.1155/2012/605101 |
0.474 |
|
2012 |
Swales KE, Moore R, Truss NJ, Tucker A, Warner TD, Negishi M, Bishop-Bailey D. Pregnane X receptor regulates drug metabolism and transport in the vasculature and protects from oxidative stress. Cardiovascular Research. 93: 674-81. PMID 22166712 DOI: 10.1093/Cvr/Cvr330 |
0.346 |
|
2011 |
Bishop-Bailey D. PPARs and angiogenesis. Biochemical Society Transactions. 39: 1601-5. PMID 22103494 DOI: 10.1042/Bst20110643 |
0.451 |
|
2011 |
Bystrom J, Wray JA, Sugden MC, Holness MJ, Swales KE, Warner TD, Edin ML, Zeldin DC, Gilroy DW, Bishop-Bailey D. Endogenous epoxygenases are modulators of monocyte/macrophage activity. Plos One. 6: e26591. PMID 22028915 DOI: 10.1371/Journal.Pone.0026591 |
0.325 |
|
2011 |
Caton PW, Holness MJ, Bishop-Bailey D, Sugden MC. PPARα-LXR as a novel metabolostatic signalling axis in skeletal muscle that acts to optimize substrate selection in response to nutrient status. The Biochemical Journal. 437: 521-30. PMID 21609322 DOI: 10.1042/Bj20110702 |
0.413 |
|
2010 |
Kapoor A, Shintani Y, Collino M, Osuchowski MF, Busch D, Patel NS, Sepodes B, Castiglia S, Fantozzi R, Bishop-Bailey D, Mota-Filipe H, Yaqoob MM, Suzuki K, Bahrami S, Desvergne B, et al. Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock. American Journal of Respiratory and Critical Care Medicine. 182: 1506-15. PMID 20693380 DOI: 10.1164/Rccm.201002-0240Oc |
0.323 |
|
2010 |
Bishop-Bailey D. The platelet as a model system for the acute actions of nuclear receptors. Steroids. 75: 570-5. PMID 19778546 DOI: 10.1016/J.Steroids.2009.09.005 |
0.37 |
|
2009 |
Wray JA, Sugden MC, Zeldin DC, Greenwood GK, Samsuddin S, Miller-Degraff L, Bradbury JA, Holness MJ, Warner TD, Bishop-Bailey D. The epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivo. Plos One. 4: e7421. PMID 19823578 DOI: 10.1371/Journal.Pone.0007421 |
0.416 |
|
2009 |
Bishop-Bailey D, Bystrom J. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation. Pharmacology & Therapeutics. 124: 141-50. PMID 19615407 DOI: 10.1016/J.Pharmthera.2009.06.011 |
0.461 |
|
2009 |
Piqueras L, Sanz MJ, Perretti M, Morcillo E, Norling L, Mitchell JA, Li Y, Bishop-Bailey D. Activation of PPARbeta/delta inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release. Journal of Leukocyte Biology. 86: 115-22. PMID 19389799 DOI: 10.1189/Jlb.0508284 |
0.426 |
|
2009 |
Bishop-Bailey D. Tumour vascularisation: a druggable target. Current Opinion in Pharmacology. 9: 96-101. PMID 19056315 DOI: 10.1016/J.Coph.2008.10.004 |
0.321 |
|
2009 |
Leontiou CA, Gueorguiev M, Hassan S, Van Der Spuy J, Lolli F, Stolbrink M, Christian HC, Wray J, Bishop-Bailey D, Berney DM, Frohman LA, Chapple JP, Grossman AB, Korbonits M. AIP, a protein mutated in familial acromegaly, plays a role in the regulation of cell proliferation and shows cell-type specific subcellular localisation Hormone Research. 71: 149-150. DOI: 10.1159/000178061 |
0.306 |
|
2008 |
Bishop-Bailey D, Swales KE. The Role of PPARs in the Endothelium: Implications for Cancer Therapy. Ppar Research. 2008: 904251. PMID 19043612 DOI: 10.1155/2008/904251 |
0.417 |
|
2008 |
Bishop-Bailey D. A Role for PPARbeta/delta in Ocular Angiogenesis. Ppar Research. 2008: 825970. PMID 18382612 DOI: 10.1155/2008/825970 |
0.333 |
|
2008 |
Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J, Stolbrink M, Christian HC, Wray J, Bishop-Bailey D, Berney DM, et al. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. The Journal of Clinical Endocrinology and Metabolism. 93: 2390-401. PMID 18381572 DOI: 10.1210/Jc.2007-2611 |
0.305 |
|
2008 |
Bishop-Bailey D. Peroxisome proliferator-activated receptor beta/delta goes vascular. Circulation Research. 102: 146-7. PMID 18239142 DOI: 10.1161/Circresaha.107.170233 |
0.344 |
|
2008 |
Wray J, Bishop-Bailey D. Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology. Experimental Physiology. 93: 148-54. PMID 17872966 DOI: 10.1113/expphysiol.2007.038612 |
0.317 |
|
2007 |
Li YT, Swales KE, Thomas GJ, Warner TD, Bishop-Bailey D. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration. Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 2606-11. PMID 18029909 DOI: 10.1161/Atvbaha.107.152694 |
0.451 |
|
2007 |
Moraes LA, Swales KE, Wray JA, Damazo A, Gibbins JM, Warner TD, Bishop-Bailey D. Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets. Blood. 109: 3741-4. PMID 17213293 DOI: 10.1182/Blood-2006-05-022566 |
0.397 |
|
2007 |
Piqueras L, Reynolds AR, Hodivala-Dilke KM, Alfranca A, Redondo JM, Hatae T, Tanabe T, Warner TD, Bishop-Bailey D. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 63-9. PMID 17068288 DOI: 10.1161/01.Atv.0000250972.83623.61 |
0.421 |
|
2006 |
Swales KE, Korbonits M, Carpenter R, Walsh DT, Warner TD, Bishop-Bailey D. The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression. Cancer Research. 66: 10120-6. PMID 17047076 DOI: 10.1158/0008-5472.Can-06-2399 |
0.369 |
|
2006 |
Bishop-Bailey D, Mitchell JA, Warner TD. COX-2 in cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 956-8. PMID 16627818 DOI: 10.1161/01.Atv.0000219672.68024.Bc |
0.35 |
|
2006 |
Warner TD, Vojnovic I, Bishop-Bailey D, Mitchell JA. Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 542-4. PMID 16403783 DOI: 10.1096/Fj.05-4434Fje |
0.301 |
|
2006 |
Ali FY, Davidson SJ, Moraes LA, Traves SL, Paul-Clark M, Bishop-Bailey D, Warner TD, Mitchell JA. Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 326-8. PMID 16368717 DOI: 10.1096/Fj.05-4395Fje |
0.382 |
|
2006 |
Ali FY, Egan K, FitzGerald GA, Desvergne B, Wahli W, Bishop-Bailey D, Warner TD, Mitchell JA. Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts. American Journal of Respiratory Cell and Molecular Biology. 34: 242-6. PMID 16239641 DOI: 10.1165/Rcmb.2005-0289Oc |
0.374 |
|
2006 |
Moraes LA, Piqueras L, Bishop-Bailey D. Peroxisome proliferator-activated receptors and inflammation. Pharmacology & Therapeutics. 110: 371-85. PMID 16168490 DOI: 10.1016/J.Pharmthera.2005.08.007 |
0.478 |
|
2006 |
Murch O, Wray J, Collin M, Bishop-Bailey D, Thiemermann C. Lysophosphatidic Acid Reduces The Organ Injury Caused By Endotoxemia Via Activation Of G-Protein-Coupled Receptors, But Not Peroxisome Proliferator-Activated Receptor?? Shock. 25: 72. DOI: 10.1097/00024382-200606001-00218 |
0.342 |
|
2004 |
Bishop-Bailey D. FXR as a novel therapeutic target for vascular disease. Drug News & Perspectives. 17: 499-504. PMID 15605109 DOI: 10.1358/Dnp.2004.17.8.863693 |
0.344 |
|
2004 |
Warner TD, Vojnovic I, Giuliano F, Jiménez R, Bishop-Bailey D, Mitchell JA. Cyclooxygenases 1, 2, and 3 and the production of prostaglandin I2: investigating the activities of acetaminophen and cyclooxygenase-2-selective inhibitors in rat tissues. The Journal of Pharmacology and Experimental Therapeutics. 310: 642-7. PMID 15148345 DOI: 10.1124/Jpet.103.063875 |
0.349 |
|
2004 |
Bishop-Bailey D, Walsh DT, Warner TD. Expression and activation of the farnesoid X receptor in the vasculature. Proceedings of the National Academy of Sciences of the United States of America. 101: 3668-73. PMID 14990788 DOI: 10.1073/Pnas.0400046101 |
0.434 |
|
2003 |
Woods M, Wood EG, Bardswell SC, Bishop-Bailey D, Barker S, Wort SJ, Mitchell JA, Warner TD. Role for nuclear factor-kappaB and signal transducer and activator of transcription 1/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells. Molecular Pharmacology. 64: 923-31. PMID 14500749 DOI: 10.1124/Mol.64.4.923 |
0.392 |
|
2003 |
Bishop-Bailey D, Warner TD. PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 1925-7. PMID 12897060 DOI: 10.1096/Fj.02-1075Fje |
0.481 |
|
2003 |
Bishop-Bailey D, Wray J. Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation. Prostaglandins & Other Lipid Mediators. 71: 1-22. PMID 12749590 DOI: 10.1016/S0090-6980(03)00003-0 |
0.416 |
|
2003 |
Patel HJ, Belvisi MG, Bishop-Bailey D, Yacoub MH, Mitchell JA. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. Journal of Immunology (Baltimore, Md. : 1950). 170: 2663-9. PMID 12594295 DOI: 10.4049/Jimmunol.170.5.2663 |
0.429 |
|
2002 |
Bishop-Bailey D, Hla T, Warner TD. Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy. Circulation Research. 91: 210-7. PMID 12169646 DOI: 10.1161/01.Res.0000029080.15742.85 |
0.589 |
|
2002 |
Bishop-Bailey D, Calatayud S, Warner TD, Hla T, Mitchell JA. Prostaglandins and the regulation of tumor growth. Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society For Environmental Toxicology and Cancer. 21: 93-101. PMID 12086407 DOI: 10.1615/Jenvironpatholtoxicoloncol.V21.I2.20 |
0.615 |
|
2001 |
Inoue K, Kawahito Y, Tsubouchi Y, Yamada R, Kohno M, Hosokawa Y, Katoh D, Bishop-Bailey D, Hla T, Sano H. Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer. Anticancer Research. 21: 2471-6. PMID 11724309 |
0.607 |
|
2000 |
Bishop-Bailey D, Hla T, Warner TD. Bisphenol A diglycidyl ether (BADGE) is a PPARgamma agonist in an ECV304 cell line. British Journal of Pharmacology. 131: 651-4. PMID 11030710 DOI: 10.1038/Sj.Bjp.0703628 |
0.621 |
|
2000 |
Kawahito Y, Kondo M, Tsubouchi Y, Hashiramoto A, Bishop-Bailey D, Inoue K, Kohno M, Yamada R, Hla T, Sano H. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. The Journal of Clinical Investigation. 106: 189-97. PMID 10903334 DOI: 10.1172/Jci9652 |
0.679 |
|
2000 |
Bishop-Bailey D. Peroxisome proliferator-activated receptors in the cardiovascular system. British Journal of Pharmacology. 129: 823-34. PMID 10696077 DOI: 10.1038/Sj.Bjp.0703149 |
0.453 |
|
2000 |
Clark RB, Bishop-Bailey D, Estrada-Hernandez T, Hla T, Puddington L, Padula SJ. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 164: 1364-71. PMID 10640751 DOI: 10.4049/Jimmunol.164.3.1364 |
0.594 |
|
1999 |
Hla T, Bishop-Bailey D, Liu CH, Schaefers HJ, Trifan OC. Cyclooxygenase-1 and -2 isoenzymes. The International Journal of Biochemistry & Cell Biology. 31: 551-7. PMID 10399316 DOI: 10.1016/S1357-2725(98)00152-6 |
0.73 |
|
1999 |
Bishop-Bailey D, Hla T. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2. The Journal of Biological Chemistry. 274: 17042-8. PMID 10358055 DOI: 10.1074/Jbc.274.24.17042 |
0.617 |
|
1999 |
Bishop-Bailey D, Hla T, Mitchell JA. Cyclo-oxygenase-2 in vascular smooth muscle. International Journal of Molecular Medicine. 3: 41-8. PMID 9864384 DOI: 10.3892/Ijmm.3.1.41 |
0.581 |
|
1998 |
Bishop-Bailey D, Pepper JR, Larkin SW, Mitchell JA. Differential induction of cyclooxygenase-2 in human arterial and venous smooth muscle: role of endogenous prostanoids. Arteriosclerosis, Thrombosis, and Vascular Biology. 18: 1655-61. PMID 9763540 DOI: 10.1161/01.Atv.18.10.1655 |
0.414 |
|
1998 |
Bishop-Bailey D, Burke-Gaffney A, Hellewell PG, Pepper JR, Mitchell JA. Cyclo-oxygenase-2 regulates inducible ICAM-1 and VCAM-1 expression in human vascular smooth muscle cells. Biochemical and Biophysical Research Communications. 249: 44-7. PMID 9705828 DOI: 10.1006/Bbrc.1998.8966 |
0.406 |
|
1998 |
Woods M, Bishop-Bailey D, Pepper JR, Evans TW, Mitchell JA, Warner TD. Cytokine and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous vein smooth-muscle cells. Journal of Cardiovascular Pharmacology. 31: S348-50. PMID 9595478 DOI: 10.1097/00005344-199800001-00097 |
0.334 |
|
1998 |
Trifan OG, Bishop-Bailey D, Hla T. Inducible cyclooxygenase-2 overexpression using the ecdysone-inducible gene expression system Faseb Journal. 12: A1384. |
0.704 |
|
1997 |
Bishop-Bailey D, Pepper JR, Haddad EB, Newton R, Larkin SW, Mitchell JA. Induction of cyclooxygenase-2 in human saphenous vein and internal mammary artery. Arteriosclerosis, Thrombosis, and Vascular Biology. 17: 1644-8. PMID 9327757 DOI: 10.1161/01.Atv.17.9.1644 |
0.323 |
|
1997 |
Bishop-Bailey D, Larkin SW, Warner TD, Chen G, Mitchell JA. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. British Journal of Pharmacology. 121: 125-33. PMID 9146896 DOI: 10.1038/Sj.Bjp.0701100 |
0.376 |
|
1994 |
Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, Willoughby DA. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proceedings of the National Academy of Sciences of the United States of America. 91: 2046-50. PMID 7510883 DOI: 10.1073/Pnas.91.6.2046 |
0.327 |
|
Show low-probability matches. |